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CASE  REPORT
Abstract:
Griscelli syndrome (GS) is a rare disease first described in 1978. It is
inherited in autosomal recessive pattern. This disease is characterized
by partial albinism, pigmentation dilution, cellular immunodeficiency,
neurological involvement & uncontrolled phases of macrophage &
lymphocyte activation.
We report a 5 months Old Iranian girl presenting with silver-gray hair,
eyelashes and eyebrows, hepatosplenomegaly, pancytopenia,
hemophagocytosis and progressive neurologic deterioration. Griscelli
syndrome can be suggested according to her symptoms. The
chemotherapy was not effective for her and she died due to multi
organ failure.
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Griscelli syndrome (GS) is a rare autosomal recessive disorder characterized by
pigmentary dilution of the hair and by abnormal regulation of the immune system
in most patients (1, 2).
Primary abnormalities include a silver grayish sheen to the hair, large pigment
agglomerations in hair shafts and abundance of mature melanosomes in melanocytes
with reduced pigmentation of adjacent keratinoncytes(1,2,3). Immunologic
abnormalities are impaired function of natural killer (NK) cells and cytotoxic T
cell (CTC). The abnormalities are characterized by absent delayed type cutaneous
hyper sensitivity; impaired major histocompatibility complex mediated cytotoxic
effects and impaired response to mitogens and sometime hypogammaglobulinemia
(1, 2, 3).
Griscelli syndrome affects young children. Clinical onset occurs between 4 months
to 4 years (2). Viral and bacterial infections can trigger that (2). The clinical
manifestations are silvery hair, recurrent infections, hepatosplenomegaly and
progressive neurologic deterioration (1,2,3,4,5,6,7,8,9,10). Laboratory features
include pancytopenia, hypofibrinogenemia, elevated level of triglyceride ,high
level of the alpha chain of the soluble interleukin II receptor and hemophagocytosis
in liver, spleen and bone marrow(3).
Genetic analysis was done in a fraction of GS patients (1, 2). Three different
genetic forms have been described in GS. (1, 11, 12, 13, 14).
GS1: mutation in the genes encoding the molecular motor protein, myosin VA
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GS2: mutation in the gene encoding the small GTPase
Rab 27a (1)
GS3: mutation in the gene that encodes melanophilin
(1)
Different mutations cause different clinical presentations
of Griscelli syndrome. On the other hand GS1 had
neurological symptoms; GS2 had immunological
symptoms, and GS3 had hypopigmentation (1).
The differential diagnosis of GS includes Chediak-Higashi
syndrome (CHS). Presence of giant cytoplasmic granules
in leukocytes on peripheral blood smear is the particular
abnormality in CHS (11, 12). Patients with Elejalde
syndrome (EJ) are also being compared with GS. EJ is
a rare autosomal recessive disease characterized by silvery
hair and severe dysfunction of central nervous system
(1). Griscelli syndrome seems to be invariably lethal
without stem cell transplantation (1). The mean age at
the time of death is about 5 years (2). So awareness of
the clinical symptoms and diagnosis criteria for GS is
crucial to starting life saving therapy in time (3).
Case Report
The patient was a 5 months girl of Iranian parents. Her
parents were relative as first cousins. She was the fourth
child and was delivered at term by normal vaginal delivery
(N.V.D) with 2600 gr body weight. Her past medical
history was uneventful until the age of 5 months when
she was referred to Mofid children's hospital because of
fever.
In physical examination she had silvery hair,
eyelashes,eyebrows, and hepatosplenomegaly (liver and
spleen 7 and 4 cm respectively below costal margin).
Laboratory data included: WBC count of 3300 cells/mm3,
PMNs 16%, lymphocytes 89%, Hb of 7.1gr/dl, Hct of
23% & platelets of 51×10 9/L. ESR 50 mm/hr, CRP (3
+), reticulocyte 3.3%, Result of direct coombs test was
negative.
There weren't any giant cytoplasmic granules in peripheral
blood smear of leukocytes. Chemical markers of serum
revealed, ALT 247 U/L (10-40), AST 227 U/L (10-40),
LDH 1150 U/L (225-400), Total bilirubin 4mg/dl (0/2-
1), direct bilirubin 2mg/dl (0-0/2), Total protein 6/2g/dl
(5-7/3), serum albumin 3gr/dl (3/8-5/4), PT & PTT were
24" (control of 12") and 48" (control of 43") respectively.
Blood sugar was 51 mg/dl (60-100 mg/dl), fibrinogen
level was 92% mg (200-400 mg %), Triglyceride was
750 mg/dl (50-200 mg/dl), ferritin was 300 ng/ml (6-140
ng/ml). serum Immunoelectrophoresis was in normal
range.
C h e s t  r a d i o g r a p h y  ( C X R )  w a s  n o r m a l .
Hepatosplenomegaly was seen in abdominal sonography.
Bone marrow aspiration and bone marrow biopsy
demonstrated hemophagocytosis without evidence of
infiltrative or malignant process. Flowcytometry results
included CD56 (21), CD11c (26), CD64 (81), CD14 (10),
CD45 (82), CD4 (26), CD8 (31) with CD4/CD8 ratio of
0.83. Examination of the hair showed irregular
agglomerations of pigment in hair shafts. According to
the above findings, the diagnosis of Griscelli syndrome
was suggested in the absence of gene analysis.
Immunosuppressive therapy including prednisolone
2mg/kg/day, IVIG 1gr/kg/day for 2 days and
cyclosporine5mg/kg/day were initiated. HLA typing with
her siblings was done, but it was not compatible. Despite
initial remission with Immunosuppressive therapy after
two months she developed neurological symptoms
including seizure, Ptosis , facial palsy and left hemiplegia.
Brain atrophy and diffuse hypodensity in white matter
were seen in brain CT results. Brain MRI showed
abnormal enhancement in the white matter. The treatment
was not effective and the patient died because of
multiorgan failure.
Discussion
In this case, the diagnosis was based on family history
(parents were first cousins), clinical features, laboratory
findings & hemophagocytosis in bone marrow aspiration
and biopsy along with light microscopic examination of
the hair with absence of giant granule in leukocytes.
Unfortunately, molecular gene analysis of this case wasn't
possible for us.
Griscelli syndrome is a rare autosomal disorder that was
first described in 1978. It has been described in
approximately 45 patients. There are many articles in the
literature about GS presentation especially neurologic
problems during last year.
Ashrafi MR (2006, Iran) reported a 6 years old boy with
silvery hair, seizure and previous history of hemiparesis
with bilateral frontal cortical and subcortical high signal
lesions, dirty white matter and high signal area in the
upper pons and both caudate and lentiform nuclei in
T2W1 in the brain MRI (5).
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Gogus S(1995, Turkey) reported bilateral diffuse
involvement of CNS, cranial nerve and spinal cord in
two cases of GS besides of other clinical features(7).
Brismar J(1992 , Saudi Arabia) reported that GS should
be added to the list of demyelinating diseases and should
be kept in mind when white matter changes are prominent
in posterior fossa (8).
Sarper N (2002, Turkey) reported a 7.5 months old girl
with GS who developed neurological symptoms after
initial hematological remission with chemotherapy. MRI
of the brain revealed an area of increased T2 signal &
abnormal enhancement in the white matter (10).
Initially, our patient gave a good response to
immunosuppressive therapy and her general condition
improved noticeably but this was a transient response
and after 2 months she developed neurological symptoms
including seizure, ptosis, facial palsy and left hemiplagia.
Stem cell transplantation was not performed because of
lack of an HLA-compatible donor and she died due to
multi organ failure.
So in Griscelli syndrome, neurologic problems should
be considered besides other clinical manifestations
including silvery hair, hepatosplenomegaly, pancytopenia
& hemophagocytosis. Awareness of the clinical symptoms
and diagnostic criteria is crucial to start life saving therapy
in time.
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